Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2025-12-25 @ 7:07 PM
Study NCT ID:
NCT01533259
Status:
COMPLETED
Last Update Posted:
2015-01-26
First Post:
2012-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-02
First Submit QC Date:
None
Study First Post Date:
2012-02-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-16
Results First Submit QC Date:
None
Results First Post Date:
2015-01-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-12-13
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-01-16
Last Update Post Date:
2015-01-26
Last Update Post Date Type:
ESTIMATED